Cigna Group CI

Financials SIC 6324 - Hospital & Medical Service Plans NAICS Finance and Insurance › Insurance Carriers and Related Activities › Insurance Carriers derived NYSE

The Cigna Group®, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company.

The Cigna Group is a global health company committed to creating a better future for every individual and every community. Powered by our dedicated people and valued brands, we advance our mission to improve the health and vitality of those we serve by staying grounded in the needs of our customers and patients - delivering a personalized, transparent and affordable health care experience. We focus on leading the way to partner and innovate solutions for better health.

At The Cigna Group our global workforce of approximately 67,700 colleagues strives to fulfill our mission to improve the health and vitality of more than 185 million customer relationships in more than 30 markets and jurisdictions (as of December 31, 2025). We play an important role in the health care system, and the breadth and depth of our customer relationships - as well as our approximately 1.7 million relationships with health care providers, clinics and facilities - give us opportunities to drive positive change.

Last close 306.95 2026-10-23
Market cap $81.11B 2026-06-30 share count
52-week range 239.51 - 316.26

Valuation FY2025 figures against the last close

P/S0.3x
P/E13.8x
P/FCF8.4x
EV/EBITDA6.1x
Dividend yield0.5%
Diluted EPS22.18

Where the revenue comes from as reported in the latest 10-K

Revenue by segment

  • Evernorth Health Services
  • Cigna Healthcare
  • Other
Revenue by segment, 3 categories over 3 years. The same figures are in the table below. FY2025 Evernorth Health Services, FY2025: 232.1B (84.8%) 85% Evernorth Health Services Cigna Healthcare, FY2025: 41.4B (15.1%) 15% Cigna Healthcare Other, FY2025: 325M (0.1%) FY2024 Evernorth Health Services, FY2024: 198.2B (80.5%) 81% Cigna Healthcare, FY2024: 47.5B (19.3%) 19% Other, FY2024: 440M (0.2%) FY2023 Evernorth Health Services, FY2023: 147.6B (76.0%) 76% Cigna Healthcare, FY2023: 46.2B (23.8%) 24% Other, FY2023: 291M (0.1%)
Segment FY2025FY2024FY2023
Evernorth Health Services $232.10B $198.18B $147.59B
Cigna Healthcare $41.43B $47.53B $46.22B
Other $325.0M $440.0M $291.0M

As the company reported it, from the “Segment Information - Revenue from External Customers (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $274.90B$247.12B$195.26B$180.52B$174.07B$160.40B$153.57B$48.65B$41.81B$39.84B
Cost of revenue $214.99B$182.51B$133.80B$124.83B$117.55B$103.48B$97.67B$4.79B$2.46B$2.47B
Gross profit $59.91B$64.61B$61.46B$55.68B$56.52B$56.92B$55.90B$43.86B$39.35B$37.37B
SG&A $14.62B$14.84B$14.82B$13.17B$13.01B$14.07B$14.05B$11.93B$10.03B$9.79B
Operating income $9.20B$9.42B$8.54B$8.45B$7.94B$8.15B$8.08B$4.16B$3.94B$3.09B
Pre-tax income $7.78B$5.27B$5.51B$8.40B$6.79B$10.87B$6.57B$3.58B$3.61B$2.98B
Income tax $1.49B$1.49B$141.0M$1.61B$1.37B$2.38B$1.45B$935.0M$1.37B$1.14B
Net income $5.96B$3.43B$5.16B$6.78B$5.42B$8.49B$5.12B$2.65B$2.23B$1.84B
EPS, basic 22.3312.2517.5721.6615.8923.1713.5810.698.927.31
EPS, diluted 22.1812.1217.3921.4115.7522.9613.4410.548.777.19
Shares, diluted (wtd. avg.) 268.6M283.2M296.9M313.1M341.0M368.4M379.8M250.2M255.1M259.6M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $7.68B$7.55B$7.87B$5.98B$5.12B$10.24B$4.67B$3.85B$2.97B$3.19B
Short-term investments $1.06B$665.0M$925.0M$905.0M$920.0M$1.33B$937.0M$2.04B$2.14B—
Receivables $28.77B$24.23B$17.72B$17.22B$15.07B$12.19B$10.72B$10.47B$3.15B—
Inventory $7.34B$6.69B$5.64B$4.78B$3.72B$3.17B$2.66B$2.82B$228.0M—
Total current assets $47.81B$48.87B$37.35B$30.12B$36.13B$27.80B$29.84B$20.43B$9.31B—
Property, plant and equipment $3.65B——$3.77B$3.69B$4.21B$4.42B$4.56B$1.56B—
Goodwill $44.92B$44.37B$44.26B$45.81B$45.81B$44.65B$44.60B$44.51B$6.16B$5.98B
Other intangibles $28.56B$29.42B$30.86B$32.49B$34.10B$35.18B$36.56B$39.00B$345.0M—
Total assets $157.92B$155.88B$152.76B$143.88B$154.89B$155.45B$155.77B$153.23B$61.76B—
Accounts payable $10.66B$9.29B$8.55B$7.78B$6.66B$5.48B$5.09B$4.37B$184.0M—
Short-term debt $592.0M$3.04B$2.77B$2.99B$2.54B$3.37B$5.51B$2.96B$131.0M—
Total current liabilities $56.34B$57.98B$48.72B$41.23B$43.57B$36.02B$40.14B$31.89B$11.01B—
Total liabilities $116.05B$114.64B$106.41B$99.13B$107.70B$105.06B$110.39B$112.15B$48.00B—
Retained earnings $47.87B$43.52B$41.65B$37.94B$32.59B$28.57B$20.16B$15.09B$15.80B—
Total equity $41.71B$41.03B$46.24B$44.69B$46.98B$50.19B$45.34B$41.03B$13.71B$13.70B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $9.60B$10.36B$11.81B$8.66B$7.19B$10.35B$9.48B$3.77B$4.09B$4.03B
Depreciation and amortisation $2.77B$2.77B$3.04B$2.94B$2.92B$2.80B$3.65B$695.0M$566.0M$610.0M
Capital expenditure ——————$1.05B$528.0M$471.0M$461.0M
Investing cash flow -$4.41B-$2.10B-$5.17B$3.10B-$3.61B$2.98B-$734.0M-$26.38B-$1.70B-$2.57B
Financing cash flow -$6.42B-$7.65B-$4.29B-$11.24B-$8.21B-$8.53B-$7.19B$23.52B-$2.65B-$225.0M
Dividends paid $401.0M$392.0M$362.0M$368.0M$357.0M$345.0M$15.0M———
Buybacks $3.62B$7.03B$2.28B$7.61B$7.74B$4.04B$1.99B$342.0M$2.73B$139.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001739940-26-000006.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 100B 200B 300B Revenue, FY2016: 39.8B Gross profit, FY2016: 37.4B Net income, FY2016: 1.8B Revenue, FY2017: 41.8B Gross profit, FY2017: 39.4B Net income, FY2017: 2.2B Revenue, FY2018: 48.6B Gross profit, FY2018: 43.9B Net income, FY2018: 2.6B Revenue, FY2019: 153.6B Gross profit, FY2019: 55.9B Net income, FY2019: 5.1B Revenue, FY2020: 160.4B Gross profit, FY2020: 56.9B Net income, FY2020: 8.5B Revenue, FY2021: 174.1B Gross profit, FY2021: 56.5B Net income, FY2021: 5.4B Revenue, FY2022: 180.5B Gross profit, FY2022: 55.7B Net income, FY2022: 6.8B Revenue, FY2023: 195.3B Gross profit, FY2023: 61.5B Net income, FY2023: 5.2B Revenue, FY2024: 247.1B Gross profit, FY2024: 64.6B Net income, FY2024: 3.4B Revenue, FY2025: 274.9B Gross profit, FY2025: 59.9B Net income, FY2025: 6B FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $39.84B $41.81B $48.65B $153.57B $160.40B $174.07B $180.52B $195.26B $247.12B $274.90B
Gross profit $37.37B $39.35B $43.86B $55.90B $56.92B $56.52B $55.68B $61.46B $64.61B $59.91B
Net income $1.84B $2.23B $2.65B $5.12B $8.49B $5.42B $6.78B $5.16B $3.43B $5.96B

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced Item 2.02
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 6324

TickerCompanyMarket capP/ERevenue growth
UNH UNITEDHEALTH GROUP INC $375.28B 31.6x 11.8%
ELV Elevance Health, Inc. $95.41B 17.5x 12.5%
HUM HUMANA INC $50.67B 42.9x 31.6%
CNC CENTENE CORP $34.66B — 20.0%
MOH MOLINA HEALTHCARE, INC. $10.92B 23.4x 11.7%
OSCR Oscar Health, Inc. $9.37B — 39.0%
CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE $2.41B — 40.3%
ALHC Alignment Healthcare, Inc. $1.67B — 46.1%